Europe is the region with the highest per capita consumption of alcohol in the world. To reduce alcohol consumption and the associated health burden, increasing taxes on alcoholic beverages is a promising policy option. Alongside ...
Sep 22, 2021
0
3
Changes in individual cancer cells over time may explain why brain tumors develop so differently, and why some cancer cells are resistant to certain treatments. To track the development of cancer cells, researchers at Uppsala ...
Sep 20, 2021
0
28
Researchers from the Case Comprehensive Cancer Center uncovered the potentially important role of the protein-coding gene, MYO10, in tumor development and immune therapy response. Their findings were published today in Science ...
Sep 15, 2021
0
65
Researchers at Tel Aviv University have printed an entire active and viable glioblastoma tumor using a 3D printer. The 3D-bioprinted tumor includes a complex system of blood vessel-like tubes through which blood cells and ...
Aug 18, 2021
0
620
A protein in tumor cells could be targeted to treat some types of aggressive cancer including brain, blood, skin, and kidney, new research has shown.
Aug 4, 2021
0
177
Keratinocyte carcinomas, including basal cell and squamous cell carcinomas, are the most common types of cancer in the United States, with approximately 5.4 million cases diagnosed each year. Despite their low mortality rate, ...
Aug 3, 2021
0
132
Drugs that target specific proteins have greatly improved patient outcomes across a broad range of tumor types; however, patients often develop drug resistance and tumor recurrence. There is a great unmet need to identify ...
Jul 29, 2021
0
36
The Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumor type.
Jul 29, 2021
0
159
Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that 'reboots' a treatment for some people with blood cancer whose cancer starts to come back.
Jun 25, 2021
0
0
A collaborative research led by immunologist Estefania Nova-Lamperti from the Universidad de Concepción (Chile), with a branch of researchers from MELISA Institute and other international academic centers, made progress ...
Jun 2, 2021
0
10
